BioSpace News Archive

DermTech Introduces PLA plus with Improved Sensitivity for Early Detection of Melanoma Leading Precision Dermatology Company Tackles Melanoma with Latest Advancement using Smart Sticker TM Technology

- GARNET study represents the largest dataset of anti-PD-1 monotherapy treatment of women with endometrial cancer - Study results showed an overall response rate of 42% - 93% of responders had a duration of response of ≥6 months

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 220,000 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today preliminary results for the first quarter of 2021. The Company expects revenues in the first quarter of 2021 to be in the range of $374 million

The Sonic Fund II, L.P. (“Sonic”), which beneficially owns approximately 6.8% of the outstanding common stock of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) (the “Company” or “Adverum”), today issued an investor presentation detailing the case for an improved Board at Adverum to better position the Company for success.

Impel NeuroPharma, Inc. (Impel), a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, today announced the pricing of its initial public offering of 5,333,334 shares of its common stock at a price to the public of $15.00 per share. All of the shares are being offered by Impel.

Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today announced the pricing of its upsized initial public offering of an aggregate of 11,250,000 shares of its common stock, 6,250,000 of which are being sold by Treace

Henry Schein, Inc. (Nasdaq:HSIC) Chairman of the Board and Chief Executive Officer Stanley M. Bergman submitted a letter to the House Select Subcommittee on the Coronavirus Crisis, urging federal officials to include primary care physicians and other office-based practitioners, including dentists, in the effort to expand COVID vaccination nationwide.

- AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2021 AACC and AACC Academy Awards.

Todos plans to commercialize Videssa in late 2021 to reduce unnecessary biopsies in the $7.19 billion mammogram naïve market and integrate it into its TBIA Platform Provista Diagnostics’ testing lab in the Atlanta, Georgia area is currently performing COVID-19 testing, that will be automated to significantly increase processing capacity Todos expects to employ testing methodologies to expand Provista’s capabilities regarding COVID variant identification